{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T04:08:33Z","timestamp":1747282113373,"version":"3.40.5"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Guangdong Basic and Applied Basic Research Fund","award":["2020A1515110173"],"award-info":[{"award-number":["2020A1515110173"]}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2021M703718"],"award-info":[{"award-number":["2021M703718"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s10067-025-07391-2","type":"journal-article","created":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T05:39:11Z","timestamp":1742189951000},"page":"1989-1998","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Human epididymis secretory protein 4 in idiopathic inflammatory myopathy-associated interstitial lung disease"],"prefix":"10.1007","volume":"44","author":[{"given":"Liubing","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Runzhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongji","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiya","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laisheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2662-5592","authenticated-orcid":false,"given":"Jianbo","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,17]]},"reference":[{"key":"7391_CR1","doi-asserted-by":"publisher","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, de Visser M et al (2017) European League Against Rheumatism\/American College of Rheumatology Classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheumatol 69(12):2271\u201382. https:\/\/doi.org\/10.1002\/art.40320","DOI":"10.1002\/art.40320"},{"key":"7391_CR2","doi-asserted-by":"publisher","unstructured":"Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14(5):269\u201378. https:\/\/doi.org\/10.1038\/nrrheum.2018.41","DOI":"10.1038\/nrrheum.2018.41"},{"key":"7391_CR3","doi-asserted-by":"publisher","unstructured":"Li S, Sun Y, Shao C, Huang H, Wang Q, Xu K et al (2021) Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases. Rheumatology (Oxford) 60(3):1195\u2013204. https:\/\/doi.org\/10.1093\/rheumatology\/keaa372","DOI":"10.1093\/rheumatology\/keaa372"},{"key":"7391_CR4","doi-asserted-by":"publisher","unstructured":"Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J et al (2018) The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77(1):30\u20139. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211868","DOI":"10.1136\/annrheumdis-2017-211868"},{"key":"7391_CR5","doi-asserted-by":"publisher","unstructured":"Furuya H, Nakajima M, Ikeda K, Nakamura K, Ohbe H, Aso S et al (2021) Prognosis and treatment of myositis-associated severe interstitial lung disease: a descriptive study using a nation-wide inpatient database in Japan. Arthritis Care Res (Hoboken). https:\/\/doi.org\/10.1002\/acr.24646","DOI":"10.1002\/acr.24646"},{"key":"7391_CR6","doi-asserted-by":"publisher","unstructured":"Gono T, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Ikeda K et al (2021) Risk prediction modeling based on a combination of initial serum biomarker levels in polymyositis\/dermatomyositis-associated interstitial lung disease. Arthritis Rheumatol 73(4):677\u201386. https:\/\/doi.org\/10.1002\/art.41566","DOI":"10.1002\/art.41566"},{"key":"7391_CR7","doi-asserted-by":"publisher","unstructured":"Johnson C, Pinal-Fernandez I, Parikh R, Paik J, Albayda J, Mammen AL et al (2016) Assessment of mortality in autoimmune myositis with and without associated interstitial lung disease. Lung 194(5):733\u20137. https:\/\/doi.org\/10.1007\/s00408-016-9896-x","DOI":"10.1007\/s00408-016-9896-x"},{"key":"7391_CR8","doi-asserted-by":"publisher","unstructured":"Hallowell RW, Danoff SK (2023) Diagnosis and management of myositis-associated lung disease. Chest. https:\/\/doi.org\/10.1016\/j.chest.2023.01.031","DOI":"10.1016\/j.chest.2023.01.031"},{"key":"7391_CR9","doi-asserted-by":"publisher","unstructured":"Troyanov Y, Targoff IN, Tremblay JL, Goulet JR, Raymond Y, Sen\u00e9cal JL (2005) Novel classification of idiopathic inflammatory myopathies based on overlap syndrome features and autoantibodies: analysis of 100 French Canadian patients. Medicine 84(4):231\u201349. https:\/\/doi.org\/10.1097\/01.md.0000173991.74008.b0","DOI":"10.1097\/01.md.0000173991.74008.b0"},{"key":"7391_CR10","doi-asserted-by":"publisher","unstructured":"McHugh NJ, Tansley SL (2018) Autoantibodies in myositis. Nat Rev Rheumatol 14(5):290\u2013302. https:\/\/doi.org\/10.1038\/nrrheum.2018.56","DOI":"10.1038\/nrrheum.2018.56"},{"key":"7391_CR11","doi-asserted-by":"publisher","unstructured":"Kayser C, Dutra LA, Dos Reis-Neto ET, Castro CHM, Fritzler MJ, Andrade LEC (2022) The role of autoantibody testing in modern personalized medicine. Clin Rev Allergy Immunol 63(2):251\u201388. https:\/\/doi.org\/10.1007\/s12016-021-08918-6","DOI":"10.1007\/s12016-021-08918-6"},{"key":"7391_CR12","doi-asserted-by":"publisher","unstructured":"Carvalho VP, Grassi ML, Palma CS, Carrara HHA, Faca VM, Candido Dos Reis FJ, et al (2019) The contribution and perspectives of proteomics to uncover ovarian cancer tumor markers. Transl Res 206:71\u201390. https:\/\/doi.org\/10.1016\/j.trsl.2018.11.001","DOI":"10.1016\/j.trsl.2018.11.001"},{"key":"7391_CR13","doi-asserted-by":"publisher","unstructured":"Galgano MT, Hampton GM, Frierson HF Jr (2006) Comprehensive analysis of HE4 expression in normal and malignant human tissues. Mod Pathol 19(6):847\u201353. https:\/\/doi.org\/10.1038\/modpathol.3800612","DOI":"10.1038\/modpathol.3800612"},{"key":"7391_CR14","doi-asserted-by":"publisher","unstructured":"Barr CE, Njoku K, Owens GL, Crosbie EJ (2023) Urine CA125 and HE4 for the detection of ovarian cancer in symptomatic women. Cancers (Basel) 15(4). https:\/\/doi.org\/10.3390\/cancers15041256","DOI":"10.3390\/cancers15041256"},{"key":"7391_CR15","doi-asserted-by":"publisher","unstructured":"Davenport C, Rai N, Sharma P, Deeks JJ, Berhane S, Mallett S et al (2022) Menopausal status, ultrasound and biomarker tests in combination for the diagnosis of ovarian cancer in symptomatic women. Cochrane Database Syst Rev 7(7):CD011964. https:\/\/doi.org\/10.1002\/14651858.CD011964.pub2","DOI":"10.1002\/14651858.CD011964.pub2"},{"key":"7391_CR16","doi-asserted-by":"publisher","unstructured":"Nagy B, Jr., Nagy B, Fila L, Clarke LA, Gonczy F, Bede O et al (2016) Human epididymis protein 4: a novel serum inflammatory biomarker in cystic fibrosis. Chest 150(3):661\u201372. https:\/\/doi.org\/10.1016\/j.chest.2016.04.006","DOI":"10.1016\/j.chest.2016.04.006"},{"key":"7391_CR17","doi-asserted-by":"publisher","unstructured":"Luo J, Wang F, Wan J, Ye Z, Huang C, Cai Y et al (2018) Serum human epididymis secretory protein 4 as a potential biomarker of renal fibrosis in kidney transplantation recipients. Clin Chim Acta 483:216\u201321. https:\/\/doi.org\/10.1016\/j.cca.2018.05.006","DOI":"10.1016\/j.cca.2018.05.006"},{"key":"7391_CR18","doi-asserted-by":"publisher","unstructured":"Raghu G, Richeldi L, Jagerschmidt A, Martin V, Subramaniam A, Ozoux ML et al (2018) Idiopathic pulmonary fibrosis: prospective, case-controlled study of natural history and circulating biomarkers. Chest 154(6):1359\u201370. https:\/\/doi.org\/10.1016\/j.chest.2018.08.1083","DOI":"10.1016\/j.chest.2018.08.1083"},{"key":"7391_CR19","doi-asserted-by":"publisher","unstructured":"Yamamoto M, Hanatani S, Araki S, Izumiya Y, Yamada T, Nakanishi N et al (2021) HE4 predicts progressive fibrosis and cardiovascular events in patients with dilated cardiomyopathy. J Am Heart Assoc 10(15):e021069. https:\/\/doi.org\/10.1161\/jaha.120.021069","DOI":"10.1161\/jaha.120.021069"},{"key":"7391_CR20","doi-asserted-by":"publisher","unstructured":"Chen J, Sun F, Bao H, Liang L, Zhan M, Yao H et al (2021) Elevated serum human epididymis protein 4 is associated with disease activity and systemic involvements in primary Sjogren\u2019s syndrome. Front Immunol 12:670642. https:\/\/doi.org\/10.3389\/fimmu.2021.670642","DOI":"10.3389\/fimmu.2021.670642"},{"key":"7391_CR21","doi-asserted-by":"publisher","unstructured":"Zhang M, Zhang L, E L, Xu K, Wang XF, Zhang B et al (2020) Increased levels of HE4 (WFDC2) in systemic sclerosis: a novel biomarker reflecting interstitial lung disease severity? Ther Adv Chronic Dis 11:2040622320956420. https:\/\/doi.org\/10.1177\/2040622320956420","DOI":"10.1177\/2040622320956420"},{"key":"7391_CR22","doi-asserted-by":"publisher","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u20137.https:\/\/doi.org\/10.1056\/NEJM197502202920807","DOI":"10.1056\/NEJM197502202920807"},{"key":"7391_CR23","doi-asserted-by":"publisher","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u20137. https:\/\/doi.org\/10.1056\/NEJM197502132920706","DOI":"10.1056\/NEJM197502132920706"},{"key":"7391_CR24","doi-asserted-by":"publisher","unstructured":"Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, Visser M et al (2017) 2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76(12):1955\u201364. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","DOI":"10.1136\/annrheumdis-2017-211468"},{"key":"7391_CR25","doi-asserted-by":"publisher","unstructured":"Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46(4):626\u201336. https:\/\/doi.org\/10.1067\/mjd.2002.120621","DOI":"10.1067\/mjd.2002.120621"},{"key":"7391_CR26","doi-asserted-by":"publisher","unstructured":"Chinniah KJ, Mody GM (2021) The spectrum of idiopathic inflammatory myopathies in South Africa. Clin Rheumatol 40(4):1437\u201346. https:\/\/doi.org\/10.1007\/s10067-020-05048-w","DOI":"10.1007\/s10067-020-05048-w"},{"key":"7391_CR27","doi-asserted-by":"publisher","unstructured":"Shenavandeh S, Rashidi F (2022) Nailfold capillaroscopy changes with disease activity in patients with inflammatory myositis including overlap myositis, pure dermatomyositis, and pure polymyositis. Reumatologia 60(1):42\u201352. https:\/\/doi.org\/10.5114\/reum.2022.114109","DOI":"10.5114\/reum.2022.114109"},{"key":"7391_CR28","doi-asserted-by":"publisher","unstructured":"Chinoy H, Fertig N, Oddis CV, Ollier WE, Cooper RG (2007) The diagnostic utility of myositis autoantibody testing for predicting the risk of cancer-associated myositis. Ann Rheum Dis 66(10):1345\u20139. https:\/\/doi.org\/10.1136\/ard.2006.068502","DOI":"10.1136\/ard.2006.068502"},{"key":"7391_CR29","doi-asserted-by":"publisher","unstructured":"Li L, Wang H, Wang Q, Wu C, Liu C, Zhang Y et al (2019) Myositis-specific autoantibodies in dermatomyositis\/polymyositis with interstitial lung disease. J Neurol Sci 397:123\u20138. https:\/\/doi.org\/10.1016\/j.jns.2018.12.040","DOI":"10.1016\/j.jns.2018.12.040"},{"key":"7391_CR30","doi-asserted-by":"publisher","unstructured":"Sun F, Zhao J, Li Y, Wang H, Cao X, Cheng W et al (2023) Human epididymis protein 4 as a clinical biomarker in identifying interstitial lung disease in patients with idiopathic inflammatory myopathies. Int Immunopharmacol 115:109609. https:\/\/doi.org\/10.1016\/j.intimp.2022.109609","DOI":"10.1016\/j.intimp.2022.109609"},{"key":"7391_CR31","doi-asserted-by":"publisher","unstructured":"Huang HL, Lin WC, Lin PY, Weng MY, Sun YT (2021) The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease. Neurol Sci 42(7):2855\u201364. https:\/\/doi.org\/10.1007\/s10072-020-04911-7","DOI":"10.1007\/s10072-020-04911-7"},{"key":"7391_CR32","doi-asserted-by":"publisher","unstructured":"Bingle L, Singleton V, Bingle CD (2002) The putative ovarian tumour marker gene HE4 (WFDC2), is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms. Oncogene 21(17):2768\u201373. https:\/\/doi.org\/10.1038\/sj.onc.1205363","DOI":"10.1038\/sj.onc.1205363"},{"key":"7391_CR33","doi-asserted-by":"publisher","unstructured":"Ohkuma R, Yada E, Ishikawa S, Komura D, Kubota Y, Hamada K et al (2021) High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer. Int J Oncol 58(1):57\u201369. https:\/\/doi.org\/10.3892\/ijo.2020.5147","DOI":"10.3892\/ijo.2020.5147"},{"key":"7391_CR34","doi-asserted-by":"publisher","unstructured":"Lv M, Wang F, Wang X, Zhang C (2019) Diagnostic value of human epididymis protein 4 in malignant pleural effusion in lung cancer. Cancer Biomark 26(4):523\u20138. https:\/\/doi.org\/10.3233\/CBM-190840","DOI":"10.3233\/CBM-190840"},{"key":"7391_CR35","doi-asserted-by":"publisher","unstructured":"Scaletta G, Plotti F, Luvero D, Capriglione S, Montera R, Miranda A et al (2017) The role of novel biomarker HE4 in the diagnosis, prognosis and follow-up of ovarian cancer: a systematic review. Expert Rev Anticancer Ther 17(9):827\u201339. https:\/\/doi.org\/10.1080\/14737140.2017.1360138","DOI":"10.1080\/14737140.2017.1360138"},{"key":"7391_CR36","doi-asserted-by":"publisher","unstructured":"Deng L, Gao Y, Li X, Cai M, Wang H, Zhuang H et al (2015) Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma. J Exp Clin Cancer Res 34:96. https:\/\/doi.org\/10.1186\/s13046-015-0208-8","DOI":"10.1186\/s13046-015-0208-8"},{"key":"7391_CR37","doi-asserted-by":"publisher","unstructured":"LeBleu VS, Teng Y, O'Connell JT, Charytan D, Muller GA, Muller CA et al (2013) Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 19(2):227\u201331. https:\/\/doi.org\/10.1038\/nm.2989","DOI":"10.1038\/nm.2989"},{"key":"7391_CR38","doi-asserted-by":"publisher","unstructured":"Bene Z, Fejes Z, Szanto TG, Fenyvesi F, Varadi J, Clarke LA et al (2021) Enhanced expression of human epididymis protein 4 (HE4) reflecting pro-inflammatory status is regulated by CFTR in cystic fibrosis bronchial epithelial cells. Front Pharmacol 12:592184. https:\/\/doi.org\/10.3389\/fphar.2021.592184","DOI":"10.3389\/fphar.2021.592184"},{"key":"7391_CR39","doi-asserted-by":"publisher","unstructured":"Oddis CV, Aggarwal R (2018) Treatment in myositis. Nat Rev Rheumatol 14(5):279\u201389. https:\/\/doi.org\/10.1038\/nrrheum.2018.42","DOI":"10.1038\/nrrheum.2018.42"},{"key":"7391_CR40","doi-asserted-by":"publisher","unstructured":"LeBleu VS, Teng Y, O'Connell JT, Charytan D, M\u00fcller GA, M\u00fcller CA et al (2013) Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis. Nat Med 19(2):227\u201331. https:\/\/doi.org\/10.1038\/nm.2989","DOI":"10.1038\/nm.2989"},{"key":"7391_CR41","doi-asserted-by":"publisher","unstructured":"Zheng W, Zou M, Hu X, Gao H, Song W, Hou Q et al (2025) Human epididymis protein 4-annexin II binding promotes aberrant epithelial-fibroblast crosstalk in pulmonary fibrosis. Commun Biol 8(1):93. https:\/\/doi.org\/10.1038\/s42003-025-07529-7","DOI":"10.1038\/s42003-025-07529-7"},{"key":"7391_CR42","doi-asserted-by":"publisher","unstructured":"Jee AS, Parker MJS, Bleasel JF, Troy LK, Lau EM, Jo HE et al (2021) Diagnosis of myositis-associated interstitial lung disease: utility of the myositis autoantibody line immunoassay. Respir Med 187:106581. https:\/\/doi.org\/10.1016\/j.rmed.2021.106581","DOI":"10.1016\/j.rmed.2021.106581"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07391-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07391-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07391-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T08:12:40Z","timestamp":1747210360000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07391-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,17]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["7391"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07391-2","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"type":"print","value":"0770-3198"},{"type":"electronic","value":"1434-9949"}],"subject":[],"published":{"date-parts":[[2025,3,17]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University in China and performed according to the guidelines of the Helsinki Declaration (No. IIT-2021-778).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}